Company Updates
3D Printing BioTech Confirms FDA Eligibility for Streamlined Regulatory Pathway | A.D.A.M’s Patented Materials and Proprietary Technology Allows Lower-Cost Offering vs Competition
“A.D.A.M. is the first-ever opportunity to print organic bones.
The key reason for us to launch this project is to help people save their lives.
TLX66 Meets Study Objectives in Patients with AL Amyloidosis
Melbourne (Australia) and Southampton (United Kingdom) – 25 May 2021. Telix announces bone marrow conditioning investigational candidate TLX66 has met study objectives, demonstrating the initial
First Patient Dosed in Japanese Prostate Cancer Imaging Study
Melbourne (Australia) and Kyoto (Japan) – 25 May 2021. Telix announces the first patient has been dosed in a clinical study in Japan using Telix’s investigational prostate cancer imaging product,
MPSS enters a Homeowners Association to secure sales rights to 30 apartments
My Property Solutions Sydney (MPSS) is proud to announce that we have entered into a HOA to secure the management and sales rights for 30 apartments in a large mixed-use development.
Revenue Generating BioTech at Pivotal Growth Point | International and Growing Client Base | In-House Intellectual Property with Growth and Monetisation Potential
“Opal’s transformation to a revenue-generating advanced formulation and manufacturing business will be achieved through the acquisition of Formulytica Pty Ltd. Formulytica offers specialist contract
Learning Pod Group has submitted a near-million dollar tender to the Western Australia Department of Education
Learning Pod Group has been working on and recently submitted a near-million dollar tender to the Western Australia Department of Education.
Rapid Response Revival receives regulatory approval to sell its first product, the automated external defibrillator branded as CellAED®, in Europe
Rapid Response Revival Research Limited is pleased to announce that its subsidiary, RRR Manufacturing Pty Ltd, has received notification that the CellAED® v2.2 has met the requirements of the
Leading e-Learning Platform with PWC and Cisco as Anchor Clients | Founders from Executive Positions at Cisco, Adobe, HP, and Vodafone
“TEX is a b2b platform that scales person-to-person learning across organisational boundaries. We do this with a consistent language of skills; an algorithm to match experts and learners; and a
Telix Pharmaceuticals and Eckert & Ziegler Sign German Distribution Agreement for Prostate Cancer Imaging
Melbourne (Australia) and Berlin (Germany) – 18 May 2021. Telix has entered an exclusive commercial distribution agreement with Eckert & Ziegler for Telix’s prostate cancer imaging product Illuccix®
Backed By Leading Investment Groups and Family Offices
